Clinical implications of cancer stem cells in digestive cancers: acquisition of stemness and prognostic impact
- 5 February 2020
- journal article
- review article
- Published by Springer Nature in Surgery Today
- Vol. 50 (12) , 1560-1577
Abstract
Digestive system cancers are the most frequent cancers worldwide and often associated with poor prognosis because of their invasive and metastatic characteristics. Recent studies have found that the plasticity of cancer cells can impart cancer stem-like properties via the epithelial–mesenchymal transition (EMT). Cancer stem-like properties such as tumor initiation are integral to the formation of metastasis, which is the main cause of poor prognosis. Numerous markers of cancer stem cells (CSCs) have been identified in many types of cancer. Therefore, CSCs, via their stem cell-like functions, may play an important role in prognosis after surgery. While several reports have described prognostic analysis using CSC markers, few reviews have summarized CSCs and their association with prognosis. Herein, we review the prognostic potential of eight CSC markers, CD133, CD44, CD90, ALDH1A1, EPCAM, SOX2, SOX9, and LGR5, in digestive cancers including those of the pancreas, colon, liver, gastric, and esophagus.Keywords
This publication has 230 references indexed in Scilit:
- Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition in Breast CancerJournal of Mammary Gland Biology and Neoplasia, 2010
- Recent patterns in gastric cancer: A global overviewInternational Journal of Cancer, 2009
- The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cellsJournal of Molecular Medicine, 2008
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical OutcomeCell Stem Cell, 2007
- Identification of stem cells in small intestine and colon by marker gene Lgr5Nature, 2007
- CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicityInternational Journal of Cancer, 2007
- Increased expression of stem cell markers in malignant melanomaLaboratory Investigation, 2007
- Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factorsThe International Journal of Biochemistry & Cell Biology, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006